On July 22, 2024, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) issued Advisory Opinion 24-05, evaluating two manufacturer-sponsored assistance programs under the federal Anti-Kickback Statute (“AKS”) and the beneficiary inducement prohibition of the Civil Monetary Penalties Law (“Beneficiary Inducement CMP”). The programs proposed offering financial aid to patients for treatment-related travel and fertility expenses. The advisory opinion was requested by a…
By: Arnall Golden Gregory LLP
By: Arnall Golden Gregory LLP
